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Abstract   
Introduction: Glucose-6-phosphate dehydrogenase deficiency (G6PD) or fauvism is the 
most common enzyme deficiency in human, so that 400 million people are living with this 
disease worldwide. This study aimed to investigate the role of some neonatal factors among 
newborns suffering from G6PD deficiency and neonatal outcomes associated with this 
disease. 
Materials and methods: In this study, two methods including case-control and retrospective 
cohort regarding some neonatal factors associated with G6PD deficiency were used. These 
methods were performed on 142 children with this kind of deficiency and 142 healthy infants 
in the city of Marvdasht during 2013- 2014. The analysis of data was based on chi-square 
tests, t-test, logistic regression, descriptive statistics and estimation of odds ratios or relative 
risks via SPSS16 software. 
Results: Totally 284 newborns including 132 (46.6%)/ 152 (53.4%) boys/girls and mean 
weight on birth of 3163 ± 471 (gr) were analyzed. Comparison of case and control samples 
did not show any significant differences between sex and involving with G6PD deficiency 
but the chance of having a baby with this defect in pregnancy intervals between 6 to 8 years 
was increased (95% CI: 1- 4.4, OR: 2). Relative risk of jaundice in infected and healthy 
infants was estimated as 3.73, which demonstrated a statistically significant association (95% 
CI: 1.33- 10.4). The frequency of low birth weight, birth order and type of delivery was 
associated with the disease, but their differences were insignificant compared to the healthy 
group. 
Conclusion: The results of this study showed that the number of hospitalization is increased 
due to jaundice in infants with G6PD. There is also an insignificant relation between low 
birth weight, rank of birth and type of delivery. Thus, it is recommended that other 
consequences of this deficiency need to be revealed by screening other populations with more 
samples.  
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deficiency (G6PD) is one of the most 
common genetic defects and about 400 
million people are living with this disease 
worldwide (1). G6PD enzyme-linked 
recessive gene has an inheritance pattern 
which is located on the X chromosome and 
therefore, often males are ill and females 
are carriers of the defect (2). This defect 
increases the susceptibility of red blood 
cells to oxidant agents such as oxidants 
present in raw beans, some medications 
and oxidative stress caused by infections 
(3) and in the case of facing with oxidative 
agents, clinical realizations of G6PD 
including acute hemolytic anemia, chronic 
hemolytic anemia and hyperbilirubinemia 
in newborns will appear and in severe 
cases it can lead to kernicterus. This severe 
complication resulting from the 
accumulation of unconjugated bilirubin in 
the brain cells at the first month of birth 
may lead to infant death, and those who 
survive  are mostly involved with mental 
retardation, disability and vestibule-
auditory disorders, seizures, hearing loss, 
speech disorders and so on (4,5). 
The frequency of G6PD deficiency in the 
Middle East is 1-2 percent in total 
population (6). In Iran, according to World 
Health Organization estimations, the 
frequency of G6PD deficiency has been 
estimated from 10 to 14.9 percent in 
general population (1), and according to 
different studies, from Iran, these 
percentages have been reported: in 
Iranshahr 24.5% (7), Yasouj 12.7% (8), 
Zahedan 5.9% (9) and Zanjan 2.1% which 
shows that the prevalence of the disease in 
different parts of the country was affected 
by ethnic, racial, and environmental 
factors. Due to the high proportion of these 
defects in our region, the World Health 
Organization suggested that in case of total 
serum bilirubin more than 7 mg/dl among 
Asian infants, or existence of coombs 
negative hemolytic anemia, the deficiency 
of the enzyme should be examined (1, 10). 
Some factors associated with G6PD 
deficiency, such as gender, familial 
marriage, hyperbilirubinemia, anemia, 
place of residence and prematurity have 
been already reported by various studies 
(9,11,13).  
Considering the high prevalence of G6PD 
deficiency in Fars province and the 
imposition of its direct and indirect costs 
on health systems and also existence of 
unfavorable clinical outcomes among 
involved babies particularly bearing some 
limitations regarding oxidizing substances 
and drugs throughout their life, 
identification of associated neonatal 
factors as well as clinical outcomes of 
babies with this defect is beneficial. This 
study aimed to investigate some neonatal 
factors associated with G6PD deficiency 
and neonatal outcomes among involved 
individuals. 
Materials and methods 
Patients: This study was performed in two 
stages and via two methods including a 
case-control and a retrospective cohort 
among 840 neonates, suspected for G6PD 
deficiency, after screening test in the city 
of Marvdasht during 2013 and 2014. For 
the current study, 142 children with 
confirmed diagnosis (through relevant 
tests) of G6PD were chosen by random 
sampling either as cases for case-control 
study or as exposed group for cohort study 
and 142 healthy newborns either as 
controls for case-control study or as non-
exposed group for cohort study.  
The frequencies of neonatal factors were 
collected by a standard questionnaire to 
identify the odds ratio and any associated 
factor for G6PD deficiency via case-
control method.  The frequencies of some 
outcomes among either exposed or non-
exposed groups, with G6PD deficiency, 
during neonatal period and their relevant 
relative risks were evaluated via cohort 
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In order to control some confounding 
variables, such as socioeconomic status 
and lifestyle, the cases and controls were 
chosen from the same health centers. 
Babies who had chronic underlying 
diseases or birth anomalies were excluded 
from the study. The analyzed variables in 
these patients included gender, birth order, 
type and intervals of pregnancy low birth 
weight, jaundice and frequency or duration 
of hospitalization during neonatal period.  
The sample size needed in this study was 
estimated based on 95% CI, 90% power 
and 5% error rate, respectively. Chi-square 
and Mann-Whitney tests were used for any 
relationship between different variables. 
Odds ratio was estimated for relevant 
variables investigated via case-control 
method and relative risk was estimated for 
relevant variables evaluated via cohort 
method. Variables associated with case-
control method were gender, type of 
delivery, birth order, birth interval, and 
those associated with cohort study were 
low birth weight, prematurity, jaundice, 
and frequency of hospitalization during 
neonatal period.  
The analysis of data was performed via 
SPSS16 software and p value less than 
0.05 was considered as significant for 
investigated variables. This study was 
approved by the Ethics Committee at the 
Ilam University of Medical Sciences. 
The study protocol conforms to the ethical 
guidelines of the 1975 Declaration of 
Helsinki as reflected in a priori approval 
by the institution\'s human research 
committee.  
Results 
In this study 284 children including 132 
boys (46.6%) and 152 girls (53.4%) were 
evaluated. Average birth weight and 
average pregnancy interval were estimated 
as 3163 ± 471 gr and 6.52±3.2 years, 
respectively. Birth characteristics of 
neonates are shown in Table 1. 
 
Table 1. Demographic characteristics of newborns, selected for G6PD deficiency study in Fars Province. 
Variables  N % 
Gender Boy 132 46.6 
Girl 152 54.4 
Birth order ≤2 231 81.6 
>2 52 18.4 
Type of delivery Caesarean section 150 57.5 
Vaginal 111 42.5 
Birth weight (gr) 2500-3500 210 75 
<2500 16 5.7 
>3500 54 19.3 
Gestational age (weeks) ≤37 6 2.1 
>37 276 97.9 
Hospitalizations because of jaundice Yes 22 7.9 
No 258 92.1 
Birth Interval (years) First child 108 38 
≤2 14 4.9 
2.1-4 36 12.7 
4.1-6 51 18 
6.1-8 35 12.3 
>8 40 14.1 
 
The results showed that the annual 
incidence of disease among girls was more 
than boys, but gender difference was not 
statistically significant (P=0.6, OR: 0.88). 
16.8 percent of infants in the case group 
and 8.5 percent of infants in the control 
group showed a pregnancy distance of 6-8 
years with significant differences, so that 
chances of having a baby with G6PD in 
pregnancy with distance of 6 to 8 years 
was 2 times more than healthy babies 
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revealed a significant relation between the 
average of distance pregnancy and the risk 
of G6PD deficiency (P= 0.048). In 
comparison with healthy infants, the 
number of G6PD-deficient infants born by 
cesarean section was more (60.2% versus 
54.9%), but using the chi-square test and 
estimating the odds ratio, there was no 
relationship between mode of delivery and 
incidence of this defect (Table 2). 
 
Table 2. Factors associated with G6PD deficiency among participants for G6PD deficiency study in Fars 
Province. 
Variable  Case number (%) Control number (%) OR (95% CI) $X2 P # 
Gender Girl 78 (54.9) 73 (51.8) 1   
Boy 64 (45.1) 68 (48.2) (1.4 – 0.55 )0.88 0.28 0.6 
Birth order 2< 23 (16.2) 29 (20.6) 1   
≥2 119 (83.8) 112 (79.4) (2.46-0.73  )1.34 0.9 0.34 
Delivery type  Vaginal 51 (39.8) 60 (45.1) 1   
Caesarean section 77 (60.2) 73 (54.9) (2.03 –0.76  )1.24 0.74 0.39 
Birth interval 
(year) 
First child 53 (37.3) 55 (38.7) 1 0.048*  
≤2 5 (3.5) 9 (3.6) (1.83-0.18  )0.58 0.89 0.35 
2.1-4 13 (9.2) 23 (16.2) (1.28-0.27  )0.59 1.82 0.18 
4.1-6 28 (19.7) 23 (16.2) (2.64-0.65  )1.26 0.47 0.49 
6.1-8 23 (16.2) 12 (8.5) (4.4-1 )2  2.93 0.08 
>8 20 (14.1) 20 (14.1 (2.14-0.5  )1.04 0.01 0.99 
OR,odds ratio.  
# Significance level 
* Mann-Whitney Test 
$ Chi square 
 
The hospitalization rates due to jaundice in 
the exposed group (G6PD deficiency) was 
estimated for 12.1% compared to only 
3.6% in the unexposed group. The relative 
risk of hospitalization due to jaundice 
caused by G6PD deficiency was calculated 
3.73 which was statistically significant (P= 
0.008). Only 6.3% of infants among 
exposed group and 5.1% of the non-
exposed group were underweight and their 
difference was not statistically significant. 
Moreover, there was no significant 
difference in the incidence rate of 
prematurity between groups (Table 3). 
  
Table 3. The relative risk of G6PD deficiency among participants for G6PD deficiency study in Fars Province. 
Variable  Case number (%) Control number (%) RR (95% CI) $X2 P # 
Birth weight (gr) 2500-3500 108 (76.1) 103 (73.9) 1 0.82*  
<2500 9 (6.3) 7 (5.1) 1.24(0.44-3.4) 0.14 0.8 
>3500 25 (17.6) 29 (21) 0.8(0.45-1.5) 0.45 0.5 
Gestational age (weeks) ≥37 139 (97.9) 137 (97.9) 0.99(0.2-4.97)   
<37 3 (2.1) 3 (2.1)  0.001 0.99 
Hospitalizations because of jaundice Yes 123 (87.9) 135 (96.4) 3.73(1.33-10.4)   
No 17 (12.1) 5 (3.6)  7.1 0.008 
RR, relative risk. 
# Significance level 
* Mann-Whitney Test 
$ Chi square 
 
Regression analysis showed that birth 
order with less than two infants (P= 0.02), 
average distance pregnancy (P= 0.02) and 
hospitalization due to jaundice (P= 0.01) 
were significantly associated with the 
occurrence of G6PD deficiency. But, there 
was no significant relation between low 
birth weight and prematurity associated 
with this defect (Table 4). Logistic 
regression model revealed a relationship 
between birth rank and G6PD deficiency 
and confirmed that increasing the distance 
between pregnancies was associated with 
increasing rate of newborns involved with 
G6PD deficiency. This analysis also 
revealed an association between neonatal 
hospitalization due to jaundice and G6PD 
deficiency; however, did not show any 
relation between low birth weight or 
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Table 4. Estimated regression coefficients of neonatal factors associated with G6PD deficiency based on 
logistic regression model. 
Variable β coefficient SE Retrograde Wald Df P* 
Birth order -0.882 0.387 5.2 1 0.023 
Birth interval -0.132 0.057 5.36 1 0.021 
Birth weight -0.17 0.8 0.04 1 0.83 
Gestational age 0.69 0.94 0.54 1 0.46 
Hospitalized because of jaundice -1.36 0.55 6.15 1 0.013 
* Significant level. SE, standard error. Df, degree of freedom. 
Discussion 
The current study revealed that the 
incidence rate of G6PD deficiency was 
higher among males than females but non- 
significantly. Our finding was in consistent 
with the results reported by Noorbakhsh 
and colleagues from Shahrekord (9), and a 
study performed in Rafsanjan by Alidalaki 
et al (12) and both of these studies 
reported non-significant relationship 
between gender and G6PD deficiency. 
However, two other studies from Amol 
(13) and Isfahan (14) reported a            
male /female ratio of 10/1 and 3/1 
respectively. Based on the Lyon’s 
hypothesis, the high risk of G6PD 
deficiency in females in some studies, 
including the present study, could be due 
to random inactivation of the X 
chromosome which is manifested in those 
heterozygous females, who have a large 
proportion of cells with the enzyme 
deficiency, through symptoms which are 
similar to those of homozygous males 
(15). 
In regards to pregnancy interval, this study 
revealed that along with increasing the 
distance between pregnancies (more than 4 
years), the risk of G6PD deficiency was 
increased too and based on both the Mann-
Whitney test and logistic regression model 
their relationship was significant. This 
relationship may be due to the age 
increasing of mothers due to longer 
pregnancy intervals, which can enhance 
genetic- related adverse effects. In this 
study, the birth order was less than 2 and 
the frequency of cesarean delivery was 
higher in infants with G6PD deficiency, 
but their relationships with the disease 
were not significant. 
In the present study, there was a 
significant relationship between G6PD 
deficiency and hospitalization due to 
jaundice; so that the risk of hospitalization 
in involved infants was 4 times more than 
healthy infants. Noorbakhsh and 
colleagues also reported an increased 
significant relation between this deficiency 
and hospitalization due to jaundice and all 
babies with jaundice had experiences of 
hospitalization too (9). Haji Ebrahim and 
colleagues also reported that in all patients 
with increased enzyme deficiency, the 
serum bilirubin and the peak incidence of 
jaundice were occurred at the first three 
days of birth (16). In our study, the 
incidence rate of G6PD was 12.1 per 100 
live births. These figures were 7.7% and 
8.8% in Amini et al. and Bahmani et al. 
studies, respectively which were lower 
than our result.  
The risk of low birth weight in newborns 
with G6PD deficiency was 1.2 times more 
than healthy babies, but their relationship 
was not significant based on chi-square 
and Mann-Whitney tests' results. There 
was no significant difference, in the 
incidence rate of prematurity, between 
groups. In a study from Tehran, conducted 
by Amini et al, no significant difference 
was observed between the risk of G6PD 
deficiency and prematurity (17), which 










































One of the limitations of this study was 
lack of some information in the newborns' 
files and also lack of data to show the 
homozygousness or heterozygousness of 
getting G6PD deficiency. 
Conclusion 
G6PD deficiency increases the risk of 
hospitalizations due to jaundice in 
newborns. There is also a relation between 
pregnancy interval of more than 4 years 
and G6PD deficiency. Though non-
significant, this enzyme deficiency leads to 
an increase in the rate of low birth weight 
babies and more need to cesarean delivery. 
Additionally, further researches with more 
samples are needed to reveal any possible 
relationship between those variables with 
higher rates among involved babies 
compared to healthy individuals, which 
were insignificant in our study.  
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